Chemical compounds and their uses
JP2026520485APending Publication Date: 2026-06-23GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD +1
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
- Filing Date
- 2024-05-31
- Publication Date
- 2026-06-23
Smart Images

Figure 2026520485000001_ABST
Abstract
A specific chemical compound of formula (I): This specification discloses chemical compounds useful for treating cancers, including cancers that are treatable by WRN inhibition, such as those characterized by microsatellite instability (MSI) and / or dysfunction of DNA mismatch repair (dMMR), and more particularly by inhibiting Werner syndrome ATP-dependent helicase enzyme (WRN) activity, and thus WRN helicase domain activity. Pharmaceutical compositions comprising such compounds, methods of using such compounds, and methods of preparing them are also disclosed.
Need to check novelty before this filing date? Find Prior Art